APA (7th ed.) Citation

C, K., MJ, B., M, G., M, T., B, B., L, A., . . . JJ, F. (2025). Peginterferon λ for the treatment of patients admitted to hospital with COVID-19: A phase 2, placebo-controlled randomized trial. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 31(12), 2048. https://doi.org/10.1016/j.cmi.2025.08.003

Chicago Style (17th ed.) Citation

C, Kandel, et al. "Peginterferon λ for the Treatment of Patients Admitted to Hospital with COVID-19: A Phase 2, Placebo-controlled Randomized Trial." Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 31, no. 12 (2025): 2048. https://doi.org/10.1016/j.cmi.2025.08.003.

MLA (9th ed.) Citation

C, Kandel, et al. "Peginterferon λ for the Treatment of Patients Admitted to Hospital with COVID-19: A Phase 2, Placebo-controlled Randomized Trial." Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, vol. 31, no. 12, 2025, p. 2048, https://doi.org/10.1016/j.cmi.2025.08.003.